Overview

Update
Status
Acquired by on January 6, 2015
Total Equity Funding
$12.92M in 2 Rounds from 7 Investors
Headquarters:
Ludwigshafen Am Rhein-oggersheim
Description:
Phenex Pharmaceuticals is a drug discovery and development company focused on developing novel pharmaceuticals.
Categories:
Pharmaceutical, Biopharma, Biotechnology
Website:
http://www.phenex-pharma.com

Company Details

Update

Phenex is a privately financed biotechnology company that focuses on developing novel drug candidates that act on Nuclear Receptors, a pharmacologically well accepted drug target class. Nuclear receptors are of major importance for the body's homeostasis, as they integrate different intra- and extracellular signalling to initiate and regulate gene expression programs. This key role in a wide variety of signalling pathways qualifies them as important pharmacological targets. Nuclear receptor modulating drugs account for about 10% revenues of the total ethical drug market, applied in different indications, such as Hormone Replacement Therapy, Women's Health, Inflammation, Diabetes, Cancer and Dermatology.

Funding Rounds (2) - $12.92M

Update
DateAmount / RoundValuationLead InvestorInvestors
Sep, 2010€6M / Series C5
Oct, 2005€4.2M / Series A2

Current Team (8)

Update

Board Members and Advisors (1)

Update

Offices/Locations (2)

Update
  • Research Site

    Waldhofer Str. 104

    Heidelberg, 69123

    DEU

  • Head Office

    Donnersbergweg 1

    Ludwigshafen Am Rhein-oggersheim, 67059

    DEU

Images (1)

Update

Add Acquisitions

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos